Toluene

Toluene

SCHEMBL5082155

Cc1ccccc1.Cl.O=C(O)O.O=C(O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Toluene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.69
TSHR P16473 2/20 0.69
ALOX12 P18054 1/20 0.69
ACHE P22303 1/20 0.69
CES2 O00748 2/20 0.56
CES1 P23141 2/20 0.56
SMN1; SMN2 Q16637 4/20 0.50
ALDH1A1 P00352 4/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
MAPT P10636 2/20 0.46
AKR1C3 P42330 1/20 0.46
POLB P06746 1/20 0.45
SRD5A2 P31213 1/20 0.44
PTGS2 P35354 1/20 0.43
CYP1B1 Q16678 1/20 0.43
VCP P55072 1/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Toluene SCHEMBL11431168 0.97 LMNA (0.65) LMNATSHRALOX12ACHECES2
Toluene SCHEMBL7355317 0.97 LMNA (0.73) LMNATSHRALOX12ACHECES2
Toluene SCHEMBL48134 0.97 LMNA (0.73) LMNATSHRALOX12ACHECES2
Toluene SCHEMBL27369787 0.97 LMNA (0.73) LMNATSHRALOX12ACHECES2
Toluene SCHEMBL2914390 0.97 LMNA (0.73) LMNATSHRALOX12ACHECES2
Toluene SCHEMBL7096668 0.94 LMNA (0.69) LMNATSHRALOX12ACHECES2
Toluene SCHEMBL7092275 0.94 LMNA (0.69) LMNATSHRALOX12ACHECES2
Toluene SCHEMBL3032586 0.94 LMNA (0.69) LMNATSHRALOX12ACHECES2
Toluene SCHEMBL28238801 0.94 LMNA (0.69) LMNATSHRALOX12ACHECES2
Toluene SCHEMBL27700453 0.94 LMNA (0.69) LMNATSHRALOX12ACHECES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080103123-A1 New compounds BIOVITRUM (SE) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103123-A1 New compounds GPR119, GPR139, GPR180 LMNA 3699/4885TSHR 488/4885ALOX12 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.